Make some medications more affordable by cutting one piece of red tape

Advocates are pushing Congress to pass the Biosimilar Red Tape Elimination Act, which aims to make medications more affordable by removing unnecessary regulatory hurdles around biologics. By eliminating the costly interchangeability standard, the bill seeks to streamline the approval process for biosimilar drugs, which are cheaper versions of biologic medicines. This move could significantly lower healthcare costs and improve access to essential treatments for millions of patients, highlighting a crucial step toward more affordable and accessible healthcare.